newsfilter
← Latest News
GlobeNewswire·

Imago BioSciences to Host Virtual Investor Event

- Company to host virtual investor event on Saturday, June 11 at 10:30 AM ET following its June 10th presentation of updated data from Phase 2 studies of bomedemstat for the treatment of Essential Thrombocythemia and Myelofibrosis at the 2022 European He